SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-018376
Filing Date
2021-05-21
Accepted
2021-05-21 16:24:04
Documents
14
Period of Report
2021-05-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10024968_8k.htm   iXBRL 8-K 39155
2 EXHIBIT 16.1 brhc10024968_ex16-1.htm EX-16.1 2781
6 image0.jpg GRAPHIC 59489
  Complete submission text file 0001140361-21-018376.txt   264641

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210521.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210521_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210521_pre.xml EX-101.PRE 16038
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10024968_8k_htm.xml XML 4225
Mailing Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151
Business Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 21949318
SIC: 2833 Medicinal Chemicals & Botanical Products